[Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Haloperidol decanoate injected every 4 weeks is a very important basic therapy for the treatment of chronic psychiatric patients. The results of this investigation compared to a long-term treatment with neuroleptic polytherapy showed a superior action of HDD monotherapy in chronic schizophrenia. The dosage schema can be adapted individually whenever necessary. Antiparkinson medication could be reduced and sometimes omitted.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008134:Long-Term Care; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; C033563:haloperidol decanoate; D006220:Haloperidol
Dauertherapie chronisch schizophrener Patienten mit Haloperidoldecanoat.